Latest Breaking News On - Brazil butantan institute - Page 23 : comparemela.com

Updated Dec. 21, 2020 6:55 pm ET SÃO PAULO—Sinovac Biotech Ltd.’s Covid-19 vaccine, which scientists hope can help combat the pandemic in the developing world, has passed the 50% threshold for efficacy in late-stage trials in Brazil, meaning regulators can give it the green light for use, people involved in its development said. Brazil is the first country to complete Phase 3 trials of the Chinese company’s CoronaVac vaccine, which is also being tested in Indonesia and Turkey. With Covid-19 largely under control in China, the country’s vaccine developers have had to conduct their clinical trials abroad. People involved in the Brazilian trials, which completed Phase 3 last week, told The Wall Street Journal that the results showed CoronaVac with an effective rate above 50%, the threshold for a vaccine to be considered viable by international scientists. The people declined to give any further information. But scientists tracking the vaccine’s d

Dimas covasBrazil butantan instituteWall streetButantan instituteDirector dimas covasடைமாஸ் கோவாஸ்பிரேசில் புத்தாண்தான் நிறுவனம்சுவர் தெருபுத்தாண்தான் நிறுவனம்இயக்குனர் டைமாஸ் கோவாஸ்